当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:270.08亿  总市值:361.81亿
流通股本:7.66亿   总股本:10.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金836,531,206.522,711,136,293.872,025,755,430.011,311,599,772.63
  收到的税费返还-35,324,766.6435,251,559.5635,251,559.56
  收到其他与经营活动有关的现金4,634,382.4194,822,421.5378,605,078.7257,606,816.47
  经营活动现金流入小计841,165,588.932,841,283,482.042,139,612,068.291,404,458,148.66
  购买商品、接受劳务支付的现金394,081,798.571,787,943,409.491,329,838,706.42928,536,616.33
  支付给职工以及为职工支付的现金314,545,623.441,206,151,226.86926,704,264.05644,115,292.77
  支付的各项税费29,296,607.61111,872,785.9189,588,618.4353,955,675.39
  支付其他与经营活动有关的现金45,392,324.32254,883,792.1136,890,747.56107,238,897.51
  经营活动现金流出小计783,316,353.943,360,851,214.362,483,022,336.461,733,846,482
  经营活动产生的现金流量净额57,849,234.99-519,567,732.32-343,410,268.17-329,388,333.34
二、投资活动产生的现金流量:
  收回投资收到的现金651,000,0002,270,000,0001,680,000,0001,180,000,000
  取得投资收益收到的现金2,550,493.159,538,557.037,390,735.15,104,981.68
  处置固定资产、无形资产和其他长期资产收回的现金净额-13,016,642.58,016,042.58,016,042.5
  收到的其他与投资活动有关的现金7,392,058.7832,707,349.6723,242,429.114,493,280.73
  投资活动现金流入小计660,942,551.932,325,262,549.21,718,649,206.71,207,614,304.91
  购建固定资产、无形资产和其他长期资产支付的现金251,907,576.74768,298,592.7509,553,908.28313,755,421.96
  投资支付的现金950,400,0023,116,756,642.412,096,966,746.751,425,794,592
  支付其他与投资活动有关的现金-20,918,197.3120,918,197.3120,918,197.31
  投资活动现金流出小计1,202,307,578.743,905,973,432.422,627,438,852.341,760,468,211.27
  投资活动产生的现金流量净额-541,365,026.81-1,580,710,883.22-908,789,645.64-552,853,906.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金-940,183,277.12940,583,277.12939,583,277.12
  其中:子公司吸收少数股东投资收到的现金-600,0001,000,000-
  取得借款收到的现金1,421,047,188.743,578,540,240.082,502,424,857.041,700,523,498.01
  发行债券收到的现金1,000,000,000---
  收到其他与筹资活动有关的现金-246,000,00090,000,000-
  筹资活动现金流入小计2,421,047,188.744,764,723,517.23,533,008,134.162,640,106,775.13
  偿还债务支付的现金582,300,0002,397,592,040.591,886,053,666.681,181,404,221.57
  分配股利、利润或偿付利息支付的现金28,011,611.3594,328,861.0470,493,903.9247,909,712.66
  支付其他与筹资活动有关的现金18,386,914.9843,496,873.1633,889,245.726,428,498.93
  筹资活动现金流出小计628,698,526.332,535,417,774.791,990,436,816.31,255,742,433.16
  筹资活动产生的现金流量净额1,792,348,662.412,229,305,742.411,542,571,317.861,384,364,341.97
四、汇率变动对现金及现金等价物的影响-12,144,143-21,706,525.95-7,377,820.48376,249.04
五、现金及现金等价物净增加额1,296,688,727.59107,320,600.92282,993,583.57502,498,351.31
  加:期初现金及现金等价物余额2,593,999,709.742,486,679,108.822,486,679,108.822,486,679,108.82
  期末现金及现金等价物余额3,890,688,437.332,593,999,709.742,769,672,692.392,989,177,460.13
补充资料:
  净利润--1,009,393,410.45--465,673,412.19
  资产减值准备-98,098,076.08-50,738,807.77
  固定资产和投资性房地产折旧-243,515,843.96-122,580,963.27
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-243,515,843.96-122,580,963.27
  无形资产摊销-35,257,393.82-16,445,543.77
  长期待摊费用摊销-5,444,464.77-3,679,404.57
  处置固定资产、无形资产和其他长期资产的损失--35,259,378.72--7,583,182.57
  固定资产报废损失-176,171.61-170,781.24
  公允价值变动损失--57,210,254.39--55,513,847.65
  财务费用-67,894,071.23-24,821,791.58
  投资损失-106,416,782.78-20,282,414.15
  递延所得税--1,263,252.01--1,870,126.71
  其中:递延所得税资产减少--1,263,252.01--1,870,126.71
  存货的减少--53,110,382.81-10,192,870.84
  经营性应收项目的减少-105,159,472.72-58,824,950.68
  经营性应付项目的增加--128,073,222.72--120,501,141.3
  其他-72,098,306.74--1,184,653.77
  现金的期末余额-2,593,999,709.74-2,989,177,460.13
  减:现金的期初余额-2,486,679,108.82-2,486,679,108.82
  现金及现金等价物的净增加额-107,320,600.92-502,498,351.31
公告日期2026-04-282026-03-142025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑